So Aroa products are:
Endoform Natural-
Endoform Antimicrobial - these two have been suggested for diabetic ulcers, chronic wounds- hard to heal wounds (seems direct competitor to PNV BTM Novosorb)
Symphony- is a product being released this year/ next year
Myriad Products (two of them) are used for surgical soft tissue reconstruction)
A future dead space management system (dead space after debridlement etc)- this is a future product
Ovitex Product- BioTech ( A US Nasdaq listed called TelaBio) are responsible for selling this for Hernia and Breast reconstruction...
It seems the main competitor to PNV is not Myriad but more Endoform.
Some key points to note is they are also using another biotech listed company to exclusively sell their Ovitex hernia and breast product- something PNV may look at doing also as they release new products.
So Aroa products are:Endoform Natural-Endoform Antimicrobial -...
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.42 |
Change
0.150(6.61%) |
Mkt cap ! $1.670B | |||
| Open | High | Low | Value | Volume |
| $2.33 | $2.42 | $2.29 | $4.630M | 1.958M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3536 | $2.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.43 | 38315 | 8 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| PNV (ASX) Chart |